Source: Business Wire

Press Release: Auspex Pharmaceuticals : Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2022 - Increasing Therapeutic Application Areas - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2022" report to their offering. The global nuclear medicine/radiopharmaceutical market is expected to reach 9,275.3 million by 2022. The nuclear medicine/radiopharmaceuticals market is expected to grow at single digit CAGR during 2015 to 2022. The factors driving the growth of this market are increased application of radiopharmaceuticals, rise in pub

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more